tiprankstipranks
Trending News
More News >

TYK Medicines, Inc Announces Board Composition and Roles

Story Highlights
TYK Medicines, Inc Announces Board Composition and Roles

Don’t Miss TipRanks’ Half-Year Sale

TYK Medicines, Inc. Class H ( (HK:2410) ) just unveiled an announcement.

TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their respective roles within the company. The board comprises executive, non-executive, and independent non-executive directors, each serving on various committees such as the Audit, Remuneration and Appraisal, Nomination, and Scientific Committees. This announcement provides clarity on the governance structure of TYK Medicines, potentially impacting its strategic direction and operational efficiency.

The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.

More about TYK Medicines, Inc. Class H

Average Trading Volume: 2,740,401

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$7.58B

See more data about 2410 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1